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Abstract: Synthesis gas, which is mainly produced from fossil fuels or biomass gasification, consists
of C1 gases such as carbon monoxide, carbon dioxide, and methane as well as hydrogen. Acetogenic
bacteria (acetogens) have emerged as an alternative solution to recycle C1 gases by converting
them into value-added biochemicals using the Wood-Ljungdahl pathway. Despite the advantage of
utilizing acetogens as biocatalysts, it is difficult to develop industrial-scale bioprocesses because of
their slow growth rates and low productivities. To solve these problems, conventional approaches to
metabolic engineering have been applied; however, there are several limitations owing to the lack
of required genetic bioparts for regulating their metabolic pathways. Recently, synthetic biology
based on genetic parts, modules, and circuit design has been actively exploited to overcome the
limitations in acetogen engineering. This review covers synthetic biology applications to design and
build industrial platform acetogens.
Keywords: acetogenic bacteria; C1 gas fixation; synthetic biology; CRISPR-Cas
1. Introduction
Acetogenic bacteria (acetogens) reduce C1 gases such as CO2 and CO, into acetyl-CoA using
the Wood-Ljungdahl (WL) pathway, and acetyl-CoA is ultimately converted into acetate. Over 100
acetogen species from 20 different genera have been isolated from diverse habitats, making the bacteria
phylogenetically and physiologically diverse with a wide range of optimal growth conditions [1–5].
Diverse acetogens have been suggested as promising biocatalysts to utilize C1 gases in synthesis
gases or waste gases generated from industries using the WL pathway. However, despite their high
industrial potential, their commercialization on the industrial scale is limited because of their slow
growth rates and low productivity when using C1 gases as their sole carbon and energy sources.
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In addition, the lack of genetic manipulation tools also makes it challenging to apply acetogens at the
industrial scale [6–10].
To overcome these hurdles, synthetic biology provides many ways to build engineered acetogens
characterized by optimal growth rates and maximal productivities. To this end, it is necessary to analyze
their metabolic pathways and energy conservation systems, along with the development of highly
efficient synthetic bioparts and genetic manipulation tools. Eventually, these efforts will build various
genetic circuits capable of producing predictable outputs in response to various input signals through
standardized components and modularization [11–15]. In recent years, various microorganisms
have been engineered to maximize their productivity by establishing predictable systems through
the development of synthetic promoters, untranslated regions (UTRs), evolved metabolic enzymes,
genome-editing tools, regulatory circuits, and chassis platforms [11,12,16–22]. If these synthetic biology
approaches are fully applied to acetogens, many of their limitations, such as the ones mentioned above,
could be resolved. This review summarizes the metabolic engineering efforts on acetogens so far and
introduces the synthetic biology approaches required for efficient C1-to-biochemical conversion.
2. Development of Genetic Manipulation Tools in Acetogens
Acetogens have high potential as biocatalysts, but there have been many difficulties in their
industrial application due to the limited availability of genetic manipulation tools. This is because
most acetogens are Gram-positive bacteria and have a thick cell wall, which makes them recalcitrant to
receiving foreign DNA molecules [10,23,24]. Nevertheless, plasmid-based gene expression methods
developed for Clostridium species have been shown to be functional in other acetogens. In addition,
many metabolic engineering efforts have recently been made using homologous recombination
(HR) [25–35], ClosTron [28,36–39] and Clustered Regularly Interspaced Short Palindromic Repeats
(CRISPR) along with its CRISPR-associated (Cas) protein (CRISPR-Cas) system [32,40–45] to improve
the production of value-added biochemicals from C1 gases.
2.1. Development of Plasmid-Based Engineering Tools in Acetogens
To express foreign DNA in acetogens, a plasmid was first constructed in E. coli and then transferred
to acetogens. Therefore, many vectors are shuttle vectors, with two replication origins for E. coli and
the target acetogen (Table 1). The pIMP1 vector usable in Clostridium aceticum, Clostridium ljungdahlii,
and Clostridium autoethanogenum consists of pIM13 of gram-positive origin and ColE1 of gram-negative
origin. Since ermC encodes the erythromycin resistance gene, erythromycin or clarithromycin could be
used as selection markers [46–49]. In the case of pJIR750ai, it has been used not only in Clostridium
species but also in Acetobacterium woodii and Eubacterium limosum. The vectors contain both pIP404 and
ColE1 of gram-positive and gram-negative bacteria origin, respectively. The antibiotic resistance gene is
catP, which encodes for chloramphenicol acetyltransferase; hence, chloramphenicol and thiamphenicol
can be used as selection markers [44,50–53]. In addition to these two plasmids, the pMTL80000 modular
vector series was developed to transfer foreign DNA between Clostridium species and E. coli. These
vectors contain plasmids of one of four gram-positive origins, pBP1, pCB102, pIM13, and pCD6, and
have p15a or ColE1 of gram-negative origins, and one of ermB, catP, or tetA as antibiotic resistance
genes [54]. These vectors have been applied in E. limosum, C. ljungdahlii, and C. autoethanogenum;
however, it was reported that their transformation efficiency in E. limosum is lower than that of the
pJIR750ai vector [44].
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Table 1. Plasmid systems applicable to acetogens.
Plasmid Gram (+)Replicon Marker
Gram (−)
Replicon Applicable Species Ref.
pIMP1 pIM13 (repL) amp/ermC ColE1 Clostridium aceticum,Clostridium ljungdahlii [46,47]
pJIR750ai pIP404 catP ColE1
Acetobacterium woodii,
Eubacterium limosum,
Clostridium ljungdahlii
[44,50,52,53]
pK18mobsacB * RP4 catP/ermB pUC Moorella thermoacetica [33,55]
pMTL82151 pBP1 (repA) catP ColE1
Clostridium ljungdahlii,
Clostridium autoethanogenum,
Eubacterium limosum
[24,30,44,54]
pMTL82254 pBP1 (repA) ermB ColE1
Clostridium ljungdahlii,
Clostridium autoethanogenum,
Eubacterium limosum
[44,54]
pMTL83151 pCB102 (repH) catP ColE1
Clostridium ljungdahlii,
Clostridium autoethanogenum,
Eubacterium limosum
[24,28,44,54,56]
pMTL83245 pIM13 (repL) ermB ColE1 Clostridium ljungdahlii,Clostridium autoethanogenum [54,57]
pMTL83353 pCB102 (repH) aad9 ColE1 Clostridium ljungdahlii,Clostridium autoethanogenum [54]
pMTL84151 pCD6 (repA) catP ColE1
Clostridium ljungdahlii,
Clostridium autoethanogenum,
Eubacterium limosum
[28,44,51,54]
pMTL84422 pCD6 (repA) tetA(P) p15a Clostridium ljungdahlii,Clostridium autoethanogenum [54]
pMTL85151 pIM13 (repL) catP ColE1
Clostridium ljungdahlii,
Clostridium autoethanogenum,
Eubacterium limosum
[44,54,58]
pMTL85241 pIM13 (repL) ermB ColE1 Clostridium ljungdahlii,Clostridium autoethanogenum [54,59]
* modified vector; ermC, ermB, erythromycin (or clarithromycin) resistance gene; catP, chloramphenicol
(thiamphenicol) resistance gene; aad9, spectinomycin resistance gene; tetA(P), tetracycline resistance gene.
2.2. Development of Genome Engineering Tools in Acetogens
The plasmid-based gene expression system has enabled the overexpression of native and
heterologous genes for desired phenotypes. However, the instability of plasmids in hosts and the
use of antibiotics for their maintenance can be problematic, especially in an industrial context [60–62].
To tackle these issues, integration of specific DNA fragments into the genome has been accomplished
through HR, allowing for stable expression of the integrated genes. In addition, the development
of several genome engineering tools such as ClosTron, transposon mutagenesis, and CRISPR-Cas
systems, has also facilitated chromosomal deletion and insertion for metabolic engineering as well as
physiological studies of acetogens (Table 2).
Table 2. Genome engineering tools used in acetogens.
Species Genetic Manipulations Ref.
ClosTron
Clostridiumautoethanogenum
Disruption of [FeFe]-hydrogenase and
[NiFe]-hydrogenase genes involved in energy
conservation
[36]
Clostridiumautoethanogenum Disruption of PCK, GAPDH, and Nfn complex genes [37]
Clostridiumautoethanogenum Disruption of acsA, cooS1, and cooS2 involved in carbonfixation [38]
Clostridiumautoethanogenum Disruption of adhE1, adhE2, aor1, and aor2 improvedethanol production to 180% [28]
Clostridiumljungdahlii Disruption of adhE1 reduced ethanol production [39]
Int. J. Mol. Sci. 2020, 21, 7639 4 of 24
Table 2. Cont.
Species Genetic Manipulations Ref.
Transposon mutagenesis
Acetobacterium woodii Insertion of Tn925 or Tn916 from E. faecalis [63]
Clostridiumljungdahlii Insertion of 5-kb acetone biosynthesis pathway viaHimar1 transposase [64]
Homologous recombination
Acetobacterium woodii Deletion of ~5-kb rnfCDGEAB by HR in ∆pyrE mutantgenerated by allelic-coupled exchange [25]
Acetobacterium woodii Deletion of ~5-kb lctCDEF by HR in ∆pyrE mutant [26]
Acetobacterium woodii Deletion of ~3-kb hydBA by HR in ∆pyrE mutant [27]
Clostridiumautoethanogenum Double deletion of two aor or adhE isoforms via allelicexchange [28]
Clostridiumljungdahlii Deletion of rnfAB by HR [29]
Clostridiumljungdahlii Deletion of fliA via double-crossover; Deletion of adhE1and adhE2 reduced ethanol production [30]
Clostridiumljungdahlii
Insertion of a butyrate production pathway by HR;
Deletion of pta, adhE1 and CLJU_c39430 via Cre-loxP
system redirected carbon and electron flux from acetate
to butyrate synthesis
[31]
Clostridiumljungdahlii Insertion of a butyric acid production pathway by phageserine integrase [32]
Moorellathermoacetica Insertion of ldh by HR in ∆pyrF mutant [33]
Thermoanaerobacter kivui Deletion of fruK in ∆pyrE mutant [34]
Thermoanaerobacter kivui Deletion of fdhF, hycB3, hycB4, and hydA2 [35]
CRISPR-Cas
Clostridiumautoethanogenum SpCas9-mediated deletion of adh and 2,3-bdh [40]
Clostridiumljungdahlii SpCas9-mediated deletion of pta, adhE1, ctf and pyrE [41]
Clostridiumljungdahlii SpCas9-mediated insertion of attB site and elimination ofspecific sites [32]
Clostridiumljungdahlii FnCas12a-mediated deletion of pyrE, pta, adhE1, and ctf [42]
Clostridiumljungdahlii Single nucleotide substitution of pta, adhE1, adhE2, aor1,and aor2 using dCas9 fused with cytidine deaminase [43]
Eubacterium limosum SpCas9-mediated insertion of ermB gene into folD andacsC for gene disruption [44]
Eubacterium limosum SpCas9-mediated deletion of pyrF [45]
2.2.1. ClosTron
ClosTron utilizes a mobile group II intron from the ltrB gene of Lactococcus lactis, which is integrated
into the target genomic site with the aid of an intron-encoded protein possessing reverse transcriptase
activity via an RNA-mediated retrohoming mechanism [65,66] (Figure 1A). Once the intron is inserted
into a specific gene in the antisense orientation, the gene function can be disrupted. This tool has
been widely demonstrated within the genus Clostridium, and hence it is termed “ClosTron” [67].
The well-established web-based ClosTron design tool streamlined the whole procedure [68,69].
Furthermore, selection markers simplified mutant isolation based on acquisition of antibiotic resistance
(e.g., clarithromycin and thiamphenicol). Among acetogens, this tool has been implemented in
C. autoethanogenum [28,36–38] and C. ljungdahlii [39]. Most of these studies utilized ClosTron to disrupt
the genes involved in carbon fixation and energy conservation, which are the keys to understanding the
basic physiology of acetogens. For instance, three isogenes encoding carbon monoxide dehydrogenase
(CODH), acsA, cooS1, and cooS2, present in C. autoethanogenum were subjected to ClosTron-based gene
inactivation. While cooS1 or cooS2 inactivation mutants exhibited no growth retardation effect under
CO or H2/CO2, the acsA mutant could not grow on both autotrophic conditions. This result indicated
that acsA is essential for carbon fixation in C. autoethanogenum [38]. Although the ClosTron system is a
valuable tool for generating deletion mutants, its use is limited by the length of an integrated DNA
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sequence, as the efficiency decreases when the sequence length exceeds 1 kb [70] and its use leaves a
scar of the inserted intron in the genome [68].Int. J. Mol. Sci. 2020, 21, x FOR PEER REVIEW 5 of 25 
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2.2.2. Transposon Mutagenesis
Non-targeted gene integration can be accomplished with transposo mutagenesis, which randomly
inserts DNA sequences into the hos chromosome (Figur 1B). The conjugative transposons T 916
and Tn925 from Enterococcus faecalis wer the first lement exploited for random gene insertio s in
A. woodii [63]. The mariner-typ Himar1 from Haematobia irritans has been utilized as an altern tive
transposon to integrate large biosynthetic pathways that are difficult to insert with ClosTron, [71,72].
Himar1 transposase inserts a DNA fragment flanked by inverted terminal repeats (ITRs) into a “TA”
target site through a “cut-and-paste” mechanism. It has been reported to deliver biosynthetic pathways
of up to 57.5 kb into the genome [73]. Recently, Himar1 was successfully applied in C. ljungdahlii to
integrate a 5 kb gene cluster (adc, thlA, ctfA-ctfB from C. acetobutylicum) for acetone production by
conjugal transfer of donor plasmids [64].
2.2.3. Homologous Recombination
Another strategy for stable genome insertion or deletion is to utilize HR. Double-crossover is
typically used for this approach and occurs in two steps (Figure 1C). The first event is a single-crossover,
in which the entire vector is incorporated into the target site through homology arms flanking a
cargo sequence. Subsequently, the second crossover removes the region between the homologous
sequences from the genome and leaves only the cargo DNA. This second recombination event occurs
at very low frequencies in acetogens, which makes screening of the desired mutant cumbersome and
time-consuming. To facilitate this, the method has been combined with the use of appropriate selectable
markers. Antibiotic resistance genes, such as ermB and catP, are widely used in acetogens as positive
selection markers that confer a selective a vantage to the host, allowing only double-crossover mutants
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to survive under selective pressures. Based on this approach, earlier efforts on HR-based gene deletion
were achieved in C. ljungdahlii [29,30]. Leang et al. [37], for instance, successfully deleted adhE1 and
adhE2 bi-functional aldehyde/alcohol dehydrogenases for ethanol production, which led to less ethanol
formation. Because of the limited number of selection markers available for C. ljungdahlii [30,31], the
Cre-loxP system has been adopted to simultaneously disrupt three genes, pta, adhE1, and CLJU_c39430,
by allowing reuse of antibiotic resistance genes [31].
On the other hand, counter-selectable markers, pyrE (orotate phophoribotransferase) and pyrF
(orotate monophosphate decarboxylase), can be used as both positive and negative selection markers.
The protocol to utilize these markers is typically performed in two steps. First, either pyrE or pyrF
in the host is inactivated and creates uracil auxotrophs, which can be isolated by the addition of
5-fluoroorotic acid (5-FOA) as it is converted to a toxic compound in the presence of either enzyme.
The mutant is subsequently complemented with a heterologous version of the respective gene
included in a donor DNA plasmid. Consequently, double-crossover mutants can be readily isolated
in uracil-free medium as they restore uracil protrophy [74]. This approach has been employed in A.
woodii [25–27], C. autoethanogenum [28], Moorella thermoacetica [33], and Thermoanaerobacter kivui [34,35].
For example, a uracil auxotrophic mutant, ∆pyrE, was first generated in A. woodii to successfully
delete rnf genes [25]. The authors used the heterologous pyrE gene from C. acetobutylicum to isolate
the rnf deletion mutant that restored uracil prototrophy. In addition to generating a single deletion
mutant, it is also possible to create double deletion mutants using the Allelic-Coupled Exchange
(ACE), which couples a counter-selection marker gene to a desired double-crossover event [75].
Using the ACE strategy, Liew et al. [28] successfully constructed double mutants, ∆aor1+2 (isoforms
of aldehyde:ferredoxin oxidoreductase) and ∆adhE1+2 (isoforms of bi-functional aldehyde/alcohol
dehydrogenase) to prove that the indirect ethanol pathway comprising aor and adh is also critical in
autotrophic ethanol production.
Besides chromosomal deletion to redirect metabolic fluxes, genomic integration of metabolic
pathways consisting of several genes is desirable to acquire a stable industrial fermentation
strain. HR-based insertion of large DNA fragments has been reported in C. ljungdahlii using
either of two approaches: HR-based single-crossover on chromosomes [31] or heterologous phage
attachment/integration (Att/Int) systems mediated by phase serine integrases [32]. These systems
showed successful integration of the butyrate production pathway comprising eight genes (thl, crt, bcd,
etfB, etfA, hbd, ptb, and buk).
2.2.4. CRISPR-Cas Genome Editing
A multitude of genetic tools discussed above have accelerated metabolic engineering and the
understanding of basic acetogen physiology. The majority of developed tools, however, still have
some bottlenecks associated with a time-consuming mutant isolation process caused by low HR
efficiency as well as inevitable scars left in the genome [30,31,36]. Recently, the CRISPR-Cas system has
been extensively used as a tool for rapid, highly efficient, and markerless genetic editing in several
model organisms [76–78]. Among the five CRISPR types [79], type II CRISPR-Cas9 from Streptococcus
pyogenes is the best-characterized system and has been successfully applied in C. autoethanogenum [40],
C. ljungdahlii [32,41,43], and E. limosum [44,45].
The CRISPR-Cas9 system consists of a Cas9 effector protein, which recognizes a 20 bp DNA
sequence adjacent to the protospacer adjacent motif (PAM), “NGG”, guided by an RNA duplex
composed of fused CRISPR RNA (crRNA) and trans-activating crRNA (tracrRNA) or engineered
single guide RNA (sgRNA). When directed to a target site within the genome, Cas9 introduces
double-stranded breaks (DSBs). In most prokaryotes, DSBs can be repaired by HR based on the donor
DNA plasmid (Figure 1D). To fully exploit this system, Cas9 and sgRNA should be expressed at
appropriate levels because Cas9 has intrinsic toxicity and the resulting DSBs can lead to cell death before
recombination can occur. Due to the limited availability of well-established genetic parts or inducible
promoters for acetogens, some studies have screened inducible promoters to tightly control Cas9
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expression. For example, in C. autoethanogenum, the initial attempt to express Cas9 under a native strong
constitutive promoter was not successful, likely due to toxicity caused by its uncontrolled expression.
Thus, a library of tetracycline-inducible promoter variants was screened, and the selected synthetic
inducible promoter, IPL12, fine-tuned Cas9 expression, leading to an improved editing efficiency
of > 50% [40]. Similarly, several well-known inducible promoters were screened for Cas9 expression in
E. limosum, and the anhydrotetracycline-inducible promoter was adopted for the CRISPR-Cas9 system
in E. limosum [44]. Following its initial exemplification in several clostridial species [80], a synthetic,
theophylline responsive riboswitch has also been exploited for Cas9-based mutant generation and
complementation studies in C. autoethanogenum [81]. For the latter, unique 24-nucleotide “bookmark”
sequences were incorporated into the mutant allele that acted as guide RNA targets during subsequent
CRISPR-Cas9-mediated replacement with the complementing wildtype allele.
General bottlenecks for applying CRISPR-Cas systems in bacteria are the requirements of DNA
cleavage, HR, and donor DNA. This renders its application even more difficult for acetogens, which
are recalcitrant to foreign DNA uptake and have low recombination efficiencies [40,41,44,45]. Recently,
an advanced genome editing tool at a one-nucleotide resolution, namely base editing, has been
developed to circumvent these bottlenecks and was demonstrated in C. ljungdahlii [43]. This tool utilizes
catalytically deactivated Cas9 (dCas9) fused with cytidine deaminase to generate cytosine-to-thymine
substitutions. It requires only a gRNA cassette for targeting, without the need to induce lethal DSBs
and offering donor DNA for recombination.
In addition to the most commonly used Cas9 protein, Cas12a (formerly known as Cpf1) [82]
was also exploited in C. ljungdahlii to better meet its low GC content (ca. 43%). Cas12a recognizes
AT-rich PAM sequences, “TTN”, which are more abundant than “NGG” for Cas9 in the genome [42].
One advantage of Cas12a is that its crRNA processing activity enhances the simplicity of multiplex
genome editing [83,84]. To target multiple genes, Cas12a requires a single promoter and terminator
to express multiple spacers and repeats, whereas Cas9 requires multiple promoters and terminators,
which increase with the number of target genes [85]. Given the complexity of metabolic networks
of the cell, it is imperative to modulate multiple genes rather than focusing on individual genetic
manipulations. Therefore, using CRISPR for simultaneous deletion or insertion of multiple genes
is worth considering when engineering acetogens for robust microbial cell factories that efficiently
convert C1 to value-added biochemicals.
3. Engineering of Acetogens for Biochemical Production
As heterogeneous DNA transfer, plasmid-based genetic manipulation, and genome engineering
tools have become established as useful techniques, studies on acetogens have largely been classified
into three main strategies. The first is to increase C1 fixing efficiency, the second is to enhance the
production of native biochemicals, and the last is to try to produce non-native biochemicals.
3.1. Improvement of C1-Fixing Pathways in Acetogens
As the plasmid-based gene expression system was developed, several studies have been conducted
to express genes related to the WL pathway, energy production, or recycling pathways to improve the
C1 gas utilization efficiency of acetogens.
3.1.1. Engineering of the WL Pathway
The WL pathway consists of a methyl branch and a carbonyl branch (Figure 2) [3,5]. To enhance
C1 fixation, genes encoding formyl-THF synthetase, methenyl-THF cyclohydrolase, methylene-THF
dehydrogenase, and methylene-THF reductase of C. ljungdahlii were expressed in A. woodii. This
mutant strain showed that acetate production was increased 1.2-fold, compared with the control strain
under autotrophic growth conditions (Table 3) [50]. The carbon monoxide dehydrgogenase/acetyl-CoA
synthase (CODH/ACS) complex plays an important role in the conversion of CO or CO2 to acetyl-CoA
in acetogens [3,5]. When genes encoding CODH are disrupted, acetogens cannot grow under
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autotrophic conditions [38]. On the other hand, when the CODH/ACS gene (CAETHG_1620-1621)
was overexpressed via the pMTL83157 plasmid in C. autoethanogenum, lag-phase growth decreased
about 4.2 days and increased the production of ethanol by 1.2-fold or lactate by 2.7-fold (Table 3) [86].
These results indicate that the CODH/ACS complex is an engineering candidate to improve cell growth
and chemical production in acetogens under autotrophic conditions.
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3.1.2. Discovery of Novel C1 Gas Fixing Pathways
In 2017, it was found that Deltaproteobacteria is capable of autotrophic growth under CO2 conditions
via the glycine synthase-reductase pathway (GSRP) [87]. Among the acetogens, Clostridium drakei was
found to have the GSRP, and it was demonstrated that the methyl branch of t e WL pathway a d GSRP
can be used ogether to redu e CO2. Acc rding these results, when the genes of gcvTH, gcvPA/B,
grdX, trxAB, and grdABCDE constituting GSRP were intr duced into E. limosum, which is k own to
lack GSRP, the growth rate and CO2 consumption ra e of he GSRP-introd ced strain increas d 1.4-fold,
and acetate production increased 2.1-fol compared to the wild-typ strain (Figure 2 and Table 3) [52].
This result expanded the pioneering perspective for increasing the efficiency of C1 gas utilization by
introducing a pathway to cooperate with the WL pathway in acetogens.
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3.2. Production of Native Biochemicals
3.2.1. Acetate
Acetogens can fix C1 gases to acetyl-CoA using one molecule of ATP via the WL pathway and then
convert it to acetate through substrate-level phosphorylation by acetate kinase (ACK) to obtain one
molecule of ATP (Figure 2). During the process of converting C1 gases into acetate, the net charge for
ATP becomes zero. Therefore, acetate is the representative native product of most acetogens because
the process of fixing C1 gases and producing acetate is a thermodynamically preferred chemical
reaction (∆G0′ = 9−0–180 kJ/mol) [88]. Improvement of acetate production has been achieved either
by overexpressing acetate biosynthesis pathways or deleting other metabolite biosynthesis pathways
that start from acetyl-CoA. In 2014, an engineered A. woodii strain was constructed to enhance acetate
production by expressing both pta and ack genes encoding a phosphotransacetylase and acetate kinase
from C. ljungdahlii, respectively, in a pJIR750ai backbone vector (Table 3) [50]. In C. ljungdahlii, when
two genes, adhE1 or adhE2, which encode putative bifunctional aldehyde/alcohol dehydrogenases,
were deleted individually or together, acetate production was increased 1.7-fold (Table 2) [30].
3.2.2. Ethanol
Ethanol can be produced from acetyl-CoA through two metabolic pathways in acetogens. The first
pathway is catalyzed by an alcohol dehydrogenase (ADH)-dependent process using two NAD(P)Hs.
The second pathway utilizes aldehyde-ferredoxin oxidoreductase (AOR) using reduced ferredoxin
and NAD(P)H (Figure 2). In particular, C. ljungdahlii, C. ragsdalei, and C. autoethanogenum strains can
produce ethanol as a native product, of which the Lanzatech process is a representative example of
the successful commercial production of bio-ethanol from C1 gases [3,6–8,28,38,46,59,89]. Ethanol
production was increased 1.5-fold by inducing the transcripts level of adhE1 genes in C. ljungdahlii [90].
Interestingly, ethanol production was specifically increased by 1.5~1.8-fold under CO autotrophic
conditions when adhE genes were deleted in C. autoethanogenum. This indicates that using the AOR
route is advantageous for ethanol production rather than the AdhE pathway in C. autoethanogenum
under CO conditions (Table 2) [28,91]. Moreover, researchers expressed heat shock proteins such as
GroEL, GroES, and DnaK in C. ljungdahlii or C. autoethanogenum, and its production was increased by
enhancing resistance to the produced ethanol (Table 3) [49,92].
3.2.3. 2,3-Butanediol (2,3-BDO)
C. ljungdahlii, C. ragsdalei, and C. autoethanogenum genomes encode genes for metabolic pathways
that produce 2,3-BDO from pyruvate through acetoin. In particular, C. autoethanogenum could produce
about 0.2 g/L of 2,3-BDO under batch culture conditions from CO steel mill gas [6,7,59]. To increase the
production of 2,3-BDO, the budC gene encoding butanediol dehydrogenase of Klebsiella pneumoniae
was expressed using the pMTL83155 vector in C. autoethanogenum. Subsequently, it produced about
0.37 g/L 2,3-BDO (Table 3) [93].
3.3. Production of Non-Native Biochemicals
3.3.1. C3: Acetone or Isopropanol
ABE fermentation is a process for producing acetone, butanol, and ethanol, which is a representative
industrial application of Clostridium strains including C. acetobutylicum [94,95]. Some efforts have been
made to produce such non-native chemicals in other acetogens, such as C. aceticum, C. ljungdahlii,
and A. woodii [47,51,64,90,96]. The acetone biosynthesis pathway begins when thiolase A (encoded
by thlA) converts acetyl-CoA to acetoacetyl-CoA, which subsequently transfers CoA to acetate via
CoA transferase (encoded by ctfAB) to produce acetoacetate. After removing CO2 by acetoacetate
decarboxylase (encoded by adc), acetone is finally produced (Figure 2). This acetone biosynthesis
pathway was constructed by expressing thlA-ctfAB-adc genes using pMTLs, pIMP, or pJIR vectors in
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several acetogens, which resulted in the production of 0.01–0.3 g/L acetone in C. aceticum, C. ljungdahlii,
C. autoethanogenum, and A. woodii from C1 gases (Table 3) [47,51,96]. In addition, the acetone biosynthesis
pathway was constructed using a lactose inducible promoter in C. ljungdahlii, and the transcriptional
expression of the corresponding genes was induced to produce 0.1 g/L of acetone from C1 gases
(Table 3) [90]. Isopropanol can be produced from acetone via alcohol dehydrogenases (encoded by adh)
using the NAD(P)H cofactor. For example, 0.648 g/L of isopropanol was obtained from C1 gases when
pMTL-thlA-ctfAB-adc-adh2 was expressed in C. autoethanogenum (Table 3) [96].
3.3.2. C4: n-Butanol or Butyrate
Butanol is another non-native product that cannot be produced by wild-type C. ljungdahlii and
C. autoethanogenum. Therefore, studies have been performed to produce 1-butanol or 2-butanol by
expressing the major butanol biosynthesis-related genes of C. acetobutylicum in the two acetogen strains.
In the case of 1-butanol, thiolase (encoded by thlA) produces acetoacetyl-CoA from two acetyl-CoA,
and 3-hydroxybutyryl-CoA dehydrogenase (encoded by hbd) is converted to 3-hydroxybutyryl-CoA.
Subsequently, crotonase (encoded by crt) converts 3-hydroxybutyryl-CoA to crotonyl-CoA, which is
then converted to butyryl-CoA by butyraldehyde dehydrogenase (encoded by bcd) and supported by an
electron transfer flavoprotein (encoded by etfAB). Finally, 1-butanol is produced through butyraldehyde
by butyraldehyde dehydrogenase using NAH(P)H (Figure 2 and Table 3). Alternatively, butyryl-CoA
can be converted to butyrate via phosphotransbutylase (encoded by ptb) and butyrate kinase (encoded
by buk), whilst also generating an ATP (Figure 2) [31,32,46,97]. This 1-butanol biosynthesis pathway was
constructed in C. ljungdahlii by expressing the three genes thlA, bdhA, and adhE via plasmid, and 148.2
mg/L of 1-butanol and 70.5 mg/L of butyrate were produced from C1 gases (Table 3) [97]. The 2-butanol
biosynthesis pathway consists of two reactions: meso-2,3-BDO is converted to 2-butanone (MEK) by
propanediol/glycerol dehydratase (encoded by pddABC), and alcohol dehydrogenase (encoded by adh)
is finally converted to 2-butanol using NAPDH (Figure 2). To produce 2-butanol in C. autoethanogenum,
a 2-butanol biosynthesis pathway was constructed by expressing als, aldc, budC, pddABC, and adh genes,
and the engineered strain produced 12.3 mg/L of 2-butanol (Table 3) [93].
3.3.3. C5: Isoprene
Isoprene is one of the C5 terpenes and it can be produced from isopentenyl pyrophosphate (IPP).
The IPP biosynthesis pathway is divided into two processes: the mevalonic acid (MVA) pathway
synthesized from acetyl-CoA or the 1-deoxyxylulose 5-phosphate synthase (DXS) pathway synthesized
from pyruvate and glycerol-3-phosphate (G3P) (Figure 2). Therefore, to produce isoprene from C1
gases, the MVA pathway or DXS pathway was introduced into C. autoethanogenum and C. ljungdahlii,
respectively, and isopentenyl pyrophosphate isomerase (encoded by idi) and isoprene synthase
(encoded by ispS) were additionally expressed [47,98]. These recombinant acetogens produced a total
of 2 ng/mL of isoprene from syngas (Table 3) [56].
3.3.4. Poly-3-hydroxybutyrate (PHB)
Poly-3-hydroxybutyrate (PHB) is a polyhydroxyalkanoate (PHA), a biodegradable plastic that is
naturally produced from Ralstonia eutropha and other microorganisms, including Alcaligenes, Pseuomonas,
Bacillus, Rhodococcus, Staphylococcus, and Micrococcus genus [99,100]. The PHB biosynthesis pathway
converts acetyl-CoA to acetoacetyl-CoA, and then synthesizes 3-hydroxybutyryl-CoA using NAD(P)H.
Subsequently, PHB can be produced through the polymerization of 3-hydroxybutyryl-CoA (Figure 2).
To produce PHB from C1 gases using C. autoethanogenum, phaA (encoding a 3-ketothiolase), phaB
(encoding an NAD(P)H-dependent acetoacetyl-CoA reductase), and phaC (encoding a PHA synthase)
were expressed in C. autoethanogenum, and then this engineered strain produced approximately 22–27
mg/L of PHB from syngas (Table 3) [101].
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Table 3. Biochemical production using the engineered acetogens.
Species Plasmids Genes Product Ref.
Clostridiumljungdahlii pIMP1,pSOBPptb thlA, bdhA, adhE Butanol [46]
Clostridiumljungdahlii pMTL85246 groES, groEL Ethanol [92]
Clostridiumautoethanogenum,
Clostridiumljungdahlii pMTL85245 thlA, crt, bhd, bcd, etfAB Butanol [97]
Moorella thermoacetica pBAD, pK18 ldh, dpyrF, g3pd Lactate [33]
Clostridiumaceticum pIMP1 thlA, ctfA/B, adc, atoDA, teII,ybgC Acetone [47]
Clostridiumautoethanogenum,
Clostridiumljungdahlii pMTL85147 thla, ctfA/B, adc
Acetone,
Isopropanol [96]
Clostridiumautoethanogenum pMTL85245,pMTL83245 malonyl-CoA reductase 3-HP [57]
Clostridiumautoethanogenum pMTL85145,pMTL83155 als, aldc, budC, adh, pddABC
2,3-BDO,
2-Butanol [93]
Clostridiumautoethanogenum pMTL85146,pMTL85246
ispS, idi, dxs, hmgs, mk, pmk,
pmd
mevalonate,
isoprene [98]
Clostridiumautoethanogenum pMTL85141,pMTL85241 budA, adh, alsS
Acetoin,
2,3-BDO [59]
Acetobacteriumwoodii pJIR750ai pta, ack, thf Acetate [50]
Clostridiumljungdahlii pAH2, pKRAH1,pCL2, pJIR-ermB
adhE1, adhE2,
thlA-ctfAB-adc
Ethanol,
acetate,
Acetone
[90]
Clostridiumljungdahlii pMCSs, pJF100s,pDWs ispS, idi
mevalonate,
isoprene [102]
Acetobacteriumwoodii pMTL84151,pJIR750ai thlA, ctfA/B, adc Acetone [51]
Clostridiumautoethanogenum pMTL83157 codh/acs Ethanol,lactate [86]
Clostridiumljungdahlii pIMP1, pXY1 thl, dnaK Ethanol,acetate [49]
Moorella thermoacetica pK18 aldh Ethanol,acetate [55]
Clostridiumljungdahlii pMTL83151,pJF100s ispS, idi
mevalonate,
isoprene [56]
Clostridiumautoethanogenum pMTL83157 phaA, phaB, phaC PHB [101]
Clostridiumljungdahlii,
Clostridiumautoethanogenum
pMTLs,
pANNE99 panBCD, bioBDF, bioHCA
Pantothenate,
Biotin,
Thiamine
[103]
Acetobacteriumwoodii pMTL83151 gusA, arcABCD Ornithine [103]
Eubacterium limosum pJIR750ai gcvTH, gcvPA/B, grdX,trxAB, grdABCDE Acetate [52]
Eubacterium limosum pJIR750ai alsSD Acetoin [53]
So far, we have demonstrated the industrial potential of acetogens as biocatalysts through
examples of various biochemicals produced from C1 gases. However, the low productivity of
non-native biochemicals is not suitable for commercial scale production despite the production
potentials [8]. To improve low productivity, it is necessary to construct genetic systems that can
control the expression level of introduced foreign genes. Most of the genes involved in producing
non-native biochemicals were regulated by native promoter/UTRs of C. acetobutylicum, C. ljungdahlii,
or C. autoethanogenum. Since these promoter/UTR parts cannot quantitatively control the level of
transcription or translation of target genes, the production of biochemicals using acetogens has
limitations in the expansion from the lab scale to the commercial scale. Therefore, it is necessary to
develop a regulatory system that can optimize the transcription or translation of each gene consisting
of artificial pathways to efficiently synthesize biochemicals from C1 gases using acetogens.
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4. Synthetic Biology Approach on Acetogens
In order to apply synthetic biology in the development of industrial platform microbes, synthetic
parts (e.g., promoters, UTRs, and transcription terminators), which are the most basic synthetic
biology units, must be developed first. To develop these parts, multi-omics information obtained from
the genome, transcriptome, translatome, interactome, proteome, and metabolome of the acetogens
of interest are required [17]. Based on these, we can not only understand their genetic regulation
system under specific culture conditions but also design artificial genetic parts to regulate gene
expression [14,15,104]. Synthetic biology is attracting attention from experts in many fields because
the artificial organisms developed in this way could show many advanced behaviors that could not be
controlled by simple gene expression such as gene deletion and overexpression. Therefore, synthetic
biology provides a very powerful principle for gene expression and regulation by developing synthetic
parts and the construction of genetic circuits.
4.1. Development of Synthetic Biology Tools in Acetogens
Many synthetic biology approaches for strain engineering are being attempted in acetogens, but
research efforts are still limited compared to other industrial microbes. First, this is due to the limited
understanding of the C1 fixation pathways of the acetogens and the genetic regulation system of
many genes involved in their carbon and energy metabolisms. Second, there is a lack of efficient
genetic manipulation tools. Third, high-throughput screening is not possible due to the lack of an
efficient reporter system such as fluorescent proteins. Therefore, if the three limitations of acetogens
are solved, more synthetic biology approaches will become applicable, and they can overcome the low
productivity of using acetogens to convert C1 gases to biochemicals.
4.1.1. Application of Multi-Omics Data with Genome-Scale Metabolic Models
With the rapid development of next-generation sequencing (NGS) technology, various omics data
have been produced, including the transcriptome in A. woodii and E. limosum as well as Clostridium
species such as C. ljungdahlii, C. autoethanogenum, and C. drakei (Table 4). Through transcriptome analysis,
it was possible to reveal the level of transcriptional expression of genes related to the WL pathway and
the energy conservation system in acetogens under autotrophic conditions [36,105–110]. In addition,
ribosome profiling in C. ljungdahlii or E. limosum revealed that translational regulation of genes in the
carbonyl-branch or energy conservation system is critical to their autotrophic growth [111,112]. Recently,
a genome-scale metabolic model (GEM) has been constructed for C. ljungdahlii, C. autoethanogenum,
and C. drakei (Table 4). GEMs contain the entire set of known biochemical reactions taking place in an
organism and allow us to predict, in silico, the flux distribution across the metabolic pathway. Based
on in silico simulation/analysis using GEMs, the carbon flux or energy balance of acetogens during
C1 fixation could be better understood [37,89,91,113–117]. This large amount of information based
on systems biology can help understand the genetic regulation system for the C1 fixation process
of acetogens.
Table 4. System-level analysis of acetogens.
Year Specices Omics-Study Ref.
2011.
Clostridiumljungdahlii,
Clostridiumautoethanogenum,
Clostridiumragsdalei
Genome [7]
2013 Clostridiumljungdahlii GEMs [118]
2013 Clostridiumljungdahlii Transcriptome [105]
2014 Clostridiumautoethanogenum Genome [119]
2015 Clostridium aceticum Genome [120]
2015 Clostridiumautoethanogenum Transcriptome [36]
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Table 4. Cont.
Year Specices Omics-Study Ref.
2015 Clostridiumautoethanogenum Genome, GEMs, transcriptomics,metabolomics, Proteomics [37]
2015 Clostridiumautoethanogenum Transcriptome [106]
2015 Clostridiumautoethanogenum Genome [121]
2015 Clostridiumljungdahlii Transcriptome [107]
2016 14 species Pan-Genome [122]
2016 Clostridiumljungdahlii GEMs [89]
2016
Clostridiumljungdahlii,
Clostridiumautoethanogenum, Clostridium
ragsdalei, Clostridium coskatii
Comparison of genome [39]
2017 Eubacterium limosum Genome, TSS [108]
2017 Clostridium autoethanogenum GEMs, transcriptome [113]
2017 Clostridium ljungdahlii Transcriptome [123]
2018 Acetobacteriumbakii Genome, TSS, Transcriptome [110]
2018 Eubacterium limosum Transcriptome, Translatome [112]
2018 Acetobacteriumwoodii Transcriptome [109]
2018 Clostridium ljungdahlii Translatome [111]
2018 Clostridium autoethanogenum GEMs, Proteomics,Metabolomics [124]
2019
Acetobacteriumpaludosum,
Acetobacteriumtundrae, Acetobacteriumbakii,
Alkalibaculum bacchi
Comparison of genome [125]
2019 Clostridium autoethanogenum GEMs [114]
2019 Clostridium ljungdahlii GEMs, Proteomics [115]
2019 Clostridium sp. AWRP Genome [126]
2020 Clostridium drakei Genome, Transcriptome, GEMs [52]
2020 Clostridium autoethanogenum GEMs, Proteomics,Metabolomics [91]
2020 Clostridium ljungdahlii GEMs, Transcriptome [116]
2020 Clostridium autoethanogenum GEMs [117]
4.1.2. Development of Synthetic Promoters in Acetogens
Genetic promoter/UTR parts, which are a basic synthetic biology unit, allow the balance between
growth and chemical production by quantitatively controlling the transcription and translation levels
of target genes or pathways. However, the development of these genetic parts has been limited to
acetogens. Using a robust native promoter such as thiolase A (Pthl) or phosphotransacetylase/acetate
kinase operon promoter (Ppta-ack), the transcription level of the target gene in the plasmid was
maintained constitutively high [39,51,59,98]. An inducible promoter system using the lactose-inducible
promoter was applied to C. ljungdahlii and C. autoethanogenum, inducing the transcriptional expression
level along with the lactose concentration [90].
In addition, information on the native promoter and 5’-UTR was revealed through differential
RNA-seq in E. limosum and A. bakii. In particular, −35, −10, and ribosome-binding sites (RBS) of
genes related to acetogenesis have strongly conserved “TTGACA”, “TATAAT’”, and “GGAGG”
motifs [108,110]. This information could expand the understanding of the native promoter and
5′-UTR in acetogens, and succeed in developing promoter parts that can be regulated according to
temperature [110]. However, these native parts may cause recombination problems with the genome
because of their high sequence similarity with the genome. They are also affected by the intracellular
transcriptional regulation system, so their functional orthogonality is limited. Therefore, synthetic
promoter/UTR parts beyond the limitations of native parts are required.
To develop synthetic parts, high-throughput screening methods using efficient reporter systems
are required (Figure 3A). However, the reporter system based on fluorescence proteins that require
oxygen has very low fluorescence intensity under anaerobic conditions [24,127,128], and FMN-based
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fluorescence proteins (LOV or FbFP) that can be used under anaerobic conditions are not sufficiently
sensitive for overcoming the auto-fluorescence of several acetogens [129–132]. Due to these problems
relating to reporter systems, the development of synthetic promoter/UTR genetic parts has not been
conducted in acetogens. However, one study on the synthetic promoter/UTR was conducted in
C. ljungdahlii. The promoter (Pthl) of the acetyl-CoA acetyltransferase gene in the C. acetobutylicum
genome was used as a backbone and a promoter/UTR library was constructed by randomization
of sequences between −35 (TTG) and −10 (TATAAT) motifs, RBS (AGGAGG), and the start codon
(ATG). The promoter library was connected upstream of the CatP-LacZ dual reporter, introduced
into C. acetobutylicum, and screened according to the concentrations of chloramphenicol and LacZ to
find synthetic promoter/UTR parts with 10-fold higher transcriptional activity than native Pthl. After
applying the genetic parts to C. ljungdahlii, it succeeded in increasing the productivity of isopropanol
19-fold compared to wild-type Pthl [49]. Indeed, this study demonstrated the capability of synthetic
promoter/UTR parts in strain engineering to enhance biochemical productivity in acetogens.
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Figure 3. Synthetic biology approach to develop chassis microbe strain. (A) High-throughput screening
of synthetic promoter/UTR parts. (B) Carbon flux redirection towards desired products through
CRISPRi-mediated repression of genes in competing pathways. (C) Genome-wide CRISPRi/a screening
for functional genomics studies. (D) Introduction of synthetic genetic circuits; Genetic regulation
system using AND, NOT, and OR gate.
In model microbes, including E. coli, biosensors that can recognize specific chemicals or
environmental stimuli have been develop d, and many of th se have b en employed for high
throughput screening of enzymes or mutant libraries according to their activities using flow
cytometry [104,133–135]. However, the m jor bottleneck for the applica ion f this approach to
acetogens is the absen of efficie t re orter systems. Thus, if efficient r p rter ystems are established,
more complex genetic circuits can be designed and applied to acetogens. Moreover, these will enable
the development of high throughput screening systems for obtaining better biochemical productivity
or enzyme activity of acetogens.
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4.2. Transcriptional Regulation System Based on CRISPR-Cas in Acetogens
4.2.1. Repurposing CRISPR-Cas System for Metabolic Engineering
Repurposing the CRISPR-Cas system for transcription regulation is a genetic tool to knockdown or
activate gene expression [18]. CRISPR interference (CRISPRi) replaces Cas9 with dCas9, which binds to
a target site without cleaving the DNA, which consequently abolishes transcription [18,136]. Although
CRISPR activation (CRISPRa) activates targeted gene expression with the assistance of transcription
activators in other organisms [137,138], a lack of well-characterized activators suitable for bacteria
has impeded CRISPRa applications in non-model organisms. In contrast, CRISPRi has shown great
potential in metabolic pathway optimization to enhance the production of target products in several
industrially important bacteria [139–144] (Figure 3B). Wu et al. [142] exploited CRISPRi in E. coli to
suppress competing genes that could divert the carbon flux towards the production of 1,4-Butanediol.
A similar approach has been shown in C. ljungdahlii, where they redirected acetyl-CoA flux from acetate
to increase the production of 3-hydroxybutyric acid (3HB) [145]. Likewise, an ethanol synthesis gene
(adhE1) was repressed with dCas12a instead of dCas9, and the redistributed carbon flux improved the
titer of butyric acid [42].
4.2.2. Genome-Wide CRISPRi/a Screening for Functional Genomic Studies
CRISPRi and CRISPRa techniques can be scaled up to the genome level. By introducing
pooled gRNA libraries that can target nearly all genes, genome-wide CRISPR screening has enabled
high-throughput functional genomics studies in bacteria [146–149] (Figure 3C). This approach can
be used to identify essential genes associated with important physiological and metabolic processes
in the cell. In acetogens, there are still large gaps in understanding the functions of unknown genes
and putative essential genes, despite many earlier biochemical and mutational studies investigating
important enzymes in the WL pathway and energy conservation pathways [4,25,29,36,38]. Using
the genome-wide CRISPRi strategy, rapid genotype-to-phenotype mapping can be accomplished in
acetogens. For example, Shin et al. conducted competitive growth assays with CRISPRi using sgRNA
pools targeting five genes in E. limosum and showed that the number of cells harboring sgRNA, which
target essential genes and hence decrease cell viability, was reduced from the initial population [44].
This study suggests the potential of genome-wide CRISPRi screening of essential and non-essential
genes under autotrophic growth in acetogens.
4.2.3. CRISPRi-Based Synthetic Genetic Circuits
Recently, CRISPRi-based synthetic genetic circuits have been designed and constructed to control
cellular behaviors to fulfill the goals of synthetic biology (Figure 3D). Nielsen et al. [150] constructed
multiple transcriptional logic gates utilizing CRISPRi, and the output of the logic circuits was used
to control cellular phenotypes, such as sugar utilization or chemotaxis in E. coli. In addition, Cress
et al. [151] constructed a library of orthogonally repressible promoters and it was incorporated into
the branched violacein biosynthesis pathway as dCas9-dependent switches capable of redirecting
carbon flux in E. coli. Employing these strategies in acetogens will allow the generation of better
microbial cell factories that can control their regulatory and metabolic pathways in response to changing
environments such as pH fluctuations and substrate availability.
5. Conclusions and Future Perspectives
The use of acetogens as biocatalysts in refining C1 gases needs to overcome several limitations
in order to adapt them to industrial-scale applications. These limitations include low growth rates,
toxicity by C1 gases and other substrates, and low productivity. The synthetic biology approach is
expected to be a very powerful way to overcome these limitations. Along with the development of
diverse bioparts and efficient genetic manipulation tools to build the targeted platform strains, the
engineered acetogens should be further optimized under the conditions of interest. To this end, the
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adaptive evolution method is straightforward and robust. Mutations are naturally generated during
adaptive evolution when a microbial strain is continuously exposed to a specific stress condition. If a
genetic mutation effectively relieves a specific stress, the strain with the mutation shows fast growth
under the specific stress conditions. There are some examples in which tolerance and growth rate of
acetogen have been improved through multiple passages under growth conditions such as methanol
or CO [53,152]. If adaptive evolution is additionally performed on acetogens, genetic variations related
to optimize the growth rate or chemical production of acetogen under stress environments can be
isolated efficiently.
Currently, there are not many examples of synthetic biology approaches for acetogens. However,
due to the recent increase in data availability for systems biology approaches and efficient genetic
manipulation tools such as CRISPR-Cas being developed, many obstacles to the synthetic biology
approach are being resolved, and therefore these tools are now rapidly being adopted to discover gene
modifications for strain optimization. Furthermore, if optimized acetogen genomes capable of highly
efficient biochemical conversion of C1 gases are built, it is expected that the currently low productivity
will be overcome, and industrial applications will increase.
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